Yes, we use industry-standard SSL technology to keep your information secure. We partner with Stripe, the industry’s established payment provider trusted by some of the world’s largest companies. Your sensitive financial information never touches our servers. We send all data directly to Stripe’s PCI-compliant servers through SSL.
Tom Murphy
Tom was diagnosed in November 2012.
In 2012 while playing golf with his son and his friends in Florida, Tom noticed a bump on his arm, where he had had a mole removed. Tom showed this to one on his son’s friends who happened to be a surgeon. Thinking that something was amiss, the surgeon took Tom to see a colleague of his, a dermatologist.
Tom had the lump removed. The lump was tested and a week later, Tom learned that the lump was, in fact, a malignant melanoma.
Tom underwent his treatment at the Mater Private under Professor John McCaffery. After a year and a half, Tom got the all clear. However, within two months the melanoma was back, when another lump appeared on his arm. His lungs had been compromised as well.
This treatment saved my life. Melanoma is a very rapid cancer, so this breakthrough is far beyond anything they, or I, had hoped for. To have come through this is a miracle of science.
Dr Janice Walshe
Dr. Janice Walshe Consultant Medical Oncologist, AMNCH, Ireland, and Member of the Marie Keating Foundation Medical Advisory Board
After obtaining her medical degree from National University of Ireland - Galway (NUIG) in 1997, Dr Walshe completed her initial oncology training in the Mater Misericordiae Hospital.
She gained her Masters in Molecular Medicine at Trinity College, Dublin. In 2003, she began her Fellowship in Medical Oncology at the National Cancer Institute (NCI) based in Bethesda, Maryland, where she was actively involved in clinical breast cancer research. She designed studies investigating novel approaches involving biological therapies in the treatment of Her-2 neu overexpressing locally advanced and metastatic breast cancer. Her research has been presented at numerous international meetings and published in peer-reviewed journals. In 2006, she returned to Ireland having been initially appointed to the Adelaide and Meath Hospital and later St Vincent’s University Hospital.
In addition to her clinical work, she is a senior lecturer at University College Dublin and Trinity College Dublin. She is an active member of the European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO) and ICORG (the all-Ireland Co-Operative Oncology Research group) ensuring the availability of novel research opportunities for Irish cancer patients. She is also a member of the ASCO Scientific Committee in triple negative breast cancer from 2013-2015.
